No dyes are added
Injection sites are chosen based on the indication: near the injury site for musculoskeletal applications, or at a standard subcutaneous site (abdomen, thigh, upper arm) for systemic and GI applications
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Anyone looking for a convenient liquid L-Carnitine formula
Direct-to-consumer GLP-1 telehealth subscriptions are generally not covered by traditional insurance plans, and compounded medications in particular are typically not reimbursable
GLP-1 therapy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)